Graeme Kay

532 total citations
18 papers, 439 citations indexed

About

Graeme Kay is a scholar working on Biochemistry, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Graeme Kay has authored 18 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 9 papers in Pathology and Forensic Medicine and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Graeme Kay's work include Biomedical Research and Pathophysiology (9 papers), Amino Acid Enzymes and Metabolism (8 papers) and Neonatal Health and Biochemistry (7 papers). Graeme Kay is often cited by papers focused on Biomedical Research and Pathophysiology (9 papers), Amino Acid Enzymes and Metabolism (8 papers) and Neonatal Health and Biochemistry (7 papers). Graeme Kay collaborates with scholars based in United Kingdom, Switzerland and France. Graeme Kay's co-authors include Paul Kong Thoo Lin, Donald Cairns, Laura Blaikie, Rachel M. Knott, Kerr H. Matthews, Barbara McKenzie, Ian L. Megson, Philip Cox, Maureen Byres and Ziad Omran and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Graeme Kay

18 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Kay United Kingdom 11 104 81 80 77 69 18 439
Giorgio Ottaviani Switzerland 14 104 1.0× 144 1.8× 24 0.3× 113 1.5× 189 2.7× 22 635
Judit Müller Hungary 12 45 0.4× 74 0.9× 17 0.2× 38 0.5× 118 1.7× 19 365
Figueroa‐Valverde Lauro Mexico 13 43 0.4× 175 2.2× 49 0.6× 39 0.5× 185 2.7× 127 632
Chatchanok Loetchutinat Thailand 10 48 0.5× 96 1.2× 14 0.2× 16 0.2× 188 2.7× 12 589
Jeffrey Sarver United States 13 48 0.5× 66 0.8× 41 0.5× 23 0.3× 204 3.0× 34 529
İpek Baysal Türkiye 16 312 3.0× 321 4.0× 40 0.5× 107 1.4× 210 3.0× 45 829
Muthusamy Ramesh India 13 40 0.4× 104 1.3× 20 0.3× 67 0.9× 201 2.9× 29 474
Livia Basile Italy 16 145 1.4× 210 2.6× 9 0.1× 90 1.2× 316 4.6× 47 697
Alix Cloarec France 9 66 0.6× 83 1.0× 9 0.1× 10 0.1× 105 1.5× 12 469
Jacques H. Poupaert Belgium 13 82 0.8× 270 3.3× 21 0.3× 11 0.1× 267 3.9× 52 636

Countries citing papers authored by Graeme Kay

Since Specialization
Citations

This map shows the geographic impact of Graeme Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Kay more than expected).

Fields of papers citing papers by Graeme Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Kay. The network helps show where Graeme Kay may publish in the future.

Co-authorship network of co-authors of Graeme Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Kay. A scholar is included among the top collaborators of Graeme Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Kay. Graeme Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blaikie, Laura, Graeme Kay, Patrı́cia Maciel, & Paul Kong Thoo Lin. (2022). Experimental modelling of Alzheimer's disease for therapeutic screening. SHILAP Revista de lepidopterología. 5. 100044–100044. 10 indexed citations
2.
Blaikie, Laura, Graeme Kay, & Paul Kong Thoo Lin. (2020). Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 30(21). 127505–127505. 22 indexed citations
3.
Blaikie, Laura, Graeme Kay, & Paul Kong Thoo Lin. (2019). Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands. MedChemComm. 10(12). 2052–2072. 87 indexed citations
4.
Kay, Graeme, et al.. (2019). Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease. MedChemComm. 10(5). 764–777. 37 indexed citations
5.
Kay, Graeme, et al.. (2017). Novel vanillin derivatives: Synthesis, anti-oxidant, DNA and cellular protection properties. European Journal of Medicinal Chemistry. 143. 745–754. 37 indexed citations
6.
McKenzie, Barbara, Graeme Kay, Kerr H. Matthews, Rachel M. Knott, & Donald Cairns. (2016). Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis. International Journal of Pharmaceutics. 515(1-2). 575–582. 21 indexed citations
7.
McKenzie, Barbara, Graeme Kay, Kerr H. Matthews, Rachel M. Knott, & Donald Cairns. (2015). The hen’s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ. International Journal of Pharmaceutics. 490(1-2). 1–8. 82 indexed citations
8.
McKenzie, Barbara & Graeme Kay. (2015). Eye gels for ophthalmic delivery. Expert Review of Ophthalmology. 10(2). 127–133. 6 indexed citations
9.
Cairns, Donald, et al.. (2013). Three salts from the reactions of cysteamine and cystamine withL-(+)-tartaric acid. Acta Crystallographica Section C Crystal Structure Communications. 69(6). 658–664. 1 indexed citations
10.
Kay, Graeme, et al.. (2012). Suppository formulations as a potential treatment for nephropathic cystinosis. Journal of Pharmaceutical Sciences. 101(10). 3729–3738. 3 indexed citations
11.
Omran, Ziad, et al.. (2011). Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis. Bioorganic & Medicinal Chemistry. 19(11). 3492–3496. 9 indexed citations
12.
Omran, Ziad, et al.. (2011). Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis. Bioorganic & Medicinal Chemistry Letters. 21(8). 2502–2504. 11 indexed citations
13.
Kay, Graeme, et al.. (2010). Gel formulations for treatment of the ophthalmic complications in cystinosis. International Journal of Pharmaceutics. 392(1-2). 192–197. 38 indexed citations
14.
Omran, Ziad, et al.. (2010). PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis. Bioorganic & Medicinal Chemistry Letters. 21(1). 45–47. 9 indexed citations
15.
16.
McCaughan, Bridgeen, Graeme Kay, Rachel M. Knott, & Donald Cairns. (2008). A potential new prodrug for the treatment of cystinosis: Design, synthesis and in-vitro evaluation. Bioorganic & Medicinal Chemistry Letters. 18(5). 1716–1719. 19 indexed citations
17.
Byres, Maureen, et al.. (2008). Supramolecular structures of six adenine-carboxylic acid complexes. CrystEngComm. 11(1). 135–142. 38 indexed citations
18.
Kay, Graeme, et al.. (2003). Assessment of Assay Sensitivity and Precision in a Malaria Antibody ELISA. Journal of Immunoassay and Immunochemistry. 24(1). 89–112. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Ottaviani Breakdown of academic impact, for papers by Judit Müller Breakdown of academic impact, for papers by Figueroa‐Valverde Lauro Breakdown of academic impact, for papers by Chatchanok Loetchutinat Breakdown of academic impact, for papers by Jeffrey Sarver Breakdown of academic impact, for papers by İpek Baysal Breakdown of academic impact, for papers by Muthusamy Ramesh Breakdown of academic impact, for papers by Livia Basile Breakdown of academic impact, for papers by Alix Cloarec Breakdown of academic impact, for papers by Jacques H. Poupaert
Rankless by CCL
2026